Bonsignori, M., Pollara, J., Moody, M. A., Kepler, T. B., Chen, X., Gurley, T. C., … Haynes, B. F. (2012). Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family. In Retrovirology (Vol. 9). Springer Science and Business Media LLC. https://doi.org/10.1186/1742-4690-9-s2-p78

Bonsignori, M., J. Pollara, M. A. Moody, T. B. Kepler, X. Chen, T. C. Gurley, D. M. Kozink, et al. “Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family.” In Retrovirology, Vol. 9. Springer Science and Business Media LLC, 2012. https://doi.org/10.1186/1742-4690-9-s2-p78.

Bonsignori M, Pollara J, Moody MA, Kepler TB, Chen X, Gurley TC, et al. Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family. In: Retrovirology. Springer Science and Business Media LLC; 2012.

Bonsignori, M., et al. “Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family.” Retrovirology, vol. 9, no. S2, Springer Science and Business Media LLC, 2012. Crossref, doi:10.1186/1742-4690-9-s2-p78.

Bonsignori M, Pollara J, Moody MA, Kepler TB, Chen X, Gurley TC, Kozink DM, Marshall DJ, Whitesides JF, Kaewkungwal J, Nitayaphan S, Pitisuttithum P, Rerks-Ngarm S, Kim JH, Michael NL, Montefiori DC, Liao H, Ferrari G, Haynes BF. Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family. Retrovirology. Springer Science and Business Media LLC; 2012.